| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $398,753 ) |
| | 2024 | 2024 | ACCEL DIAGNOSTICS, LLC | 6009 RICHMOND AVE STE 130 | HOUSTON | TX | 77057-6218 | HARRIS | USA | R44AI157776 | A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer. | 000 | 4 | NIH | 2/5/2024 | $398,753 |
|
| Issue Date FY: 2023 ( Subtotal = $88,693 ) |
| | 2023 | 2023 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN | HOUSTON | TX | 77057-7100 | HARRIS | USA | R44AI157776 | A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer. | 001 | 3 | NIH | 4/20/2023 | $97,316 |
| | 2023 | 2021 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN | HOUSTON | TX | 77057-7100 | HARRIS | USA | R44AI157776 | A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer. | 000 | 1 | NIH | 2/2/2023 | -$8,623 |
| | 2023 | 2020 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN | HOUSTON | TX | 77057-7100 | HARRIS | USA | R43NS115309 | A rapid blood test to aid the triage of patients affected by head injuries. | 000 | 1 | NIH | 9/12/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $963,581 ) |
| | 2022 | 2022 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R44AI157776 | A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer. | 000 | 2 | NIH | 2/16/2022 | $963,581 |
|
| Issue Date FY: 2021 ( Subtotal = $240,405 ) |
| | 2021 | 2021 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R44AI157776 | A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer. | 000 | 1 | NIH | 2/3/2021 | $240,405 |
| | 2021 | 2019 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R43HD097888 | A Rapid Non-Invasive Device for Monitoring Preeclampsia in High Risk Pregnancy | 000 | 1 | NIH | 2/13/2021 | $0 |
| | 2021 | 2018 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R44HL127880 | A disposable assay for the monitoring of heart failure in the home setting. | 000 | 3 | NIH | 11/18/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $223,966 ) |
| | 2020 | 2020 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R43NS115309 | A rapid blood test to aid the triage of patients affected by head injuries. | 000 | 1 | NIH | 8/25/2020 | $223,966 |
|
| Issue Date FY: 2019 ( Subtotal = $215,450 ) |
| | 2019 | 2019 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R43HD097888 | A Rapid Non-Invasive Device for Monitoring Preeclampsia in High Risk Pregnancy | 000 | 1 | NIH | 2/26/2019 | $215,450 |
|
| Issue Date FY: 2018 ( Subtotal = $331,659 ) |
| | 2018 | 2018 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R44HL127880 | A disposable assay for the monitoring of heart failure in the home setting. | 000 | 3 | NIH | 7/26/2018 | $331,659 |
| | 2018 | 2017 | ACCEL DIAGNOSTICS, LLC | 5930 STAR LN SUITE C | HOUSTON | TX | 77057-7100 | HARRIS | USA | R43AI125013 | I-Corps Program for A rapid instrument-free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood. | 000 | 1 | NIH | 4/9/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $661,011 ) |
| | 2017 | 2017 | ACCEL DIAGNOSTICS, LLC | 5750 BAUM BLVD # 310 | PITTSBURGH | PA | 15206-3793 | ALLEGHENY | USA | R43AI125013 | I-Corps Program for A rapid instrument-free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood. | 001 | 1 | NIH | 5/18/2017 | $8,299 |
| | 2017 | 2017 | ACCEL DIAGNOSTICS, LLC | 5750 BAUM BLVD # 310 | PITTSBURGH | PA | 15206-3793 | ALLEGHENY | USA | R44HL127880 | A disposable assay for the monitoring of heart failure in the home setting. | 000 | 2 | NIH | 8/7/2017 | $611,965 |
| | 2017 | 2017 | ACCEL DIAGNOSTICS, LLC | 5750 BAUM BLVD # 310 | PITTSBURGH | PA | 15206-3793 | ALLEGHENY | USA | R43AI125013 | I-Corps Program for A rapid instrument-free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood. | 000 | 1 | NIH | 4/5/2017 | $40,747 |
|
| Issue Date FY: 2016 ( Subtotal = $145,499 ) |
| | 2016 | 2016 | ACCEL DIAGNOSTICS LLC | 3500 5TH AVENUE | PITTSBURGH | PA | 15213 | ALLEGHENY | USA | R43AI125013 | I-Corps Program for A rapid instrument-free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood. | 000 | 1 | NIH | 6/14/2016 | $145,499 |
|
| Issue Date FY: 2015 ( Subtotal = $225,133 ) |
| | 2015 | 2015 | ACCEL DIAGNOSTICS LLC | 3500 5TH AVENUE | PITTSBURGH | PA | 15213 | ALLEGHENY | USA | R43HL127880 | A disposable assay for the monitoring of heart failure in the home setting | 000 | 1 | NIH | 3/23/2015 | $225,133 |
|
| Issue Date FY: 2013 ( Subtotal = $168,846 ) |
| | 2013 | 2013 | ACCEL DIAGNOSTICS LLC | 3500 5TH AVENUE | PITTSBURGH | PA | 15213 | ALLEGHENY | USA | R43HL110508 | BLOOD FILTRATION SYSTEM FOR THE TREATMENT OF SEVERE MALARIA PATIENTS | 000 | 2 | NIH | 8/1/2013 | $168,846 |
|
| Issue Date FY: 2012 ( Subtotal = $355,563 ) |
| | 2012 | 2012 | ACCEL DIAGNOSTICS LLC | 3500 5TH AVENUE | PITTSBURGH | PA | 15213 | ALLEGHENY | USA | R43HL110508 | BLOOD FILTRATION SYSTEM FOR THE TREATMENT OF SEVERE MALARIA PATIENTS | 000 | 1 | NIH | 8/16/2012 | $355,563 |
|
|
